Company / Shares Outstanding
Ovid Therapeutics Inc. Shares Outstanding History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
71.0M
FY2025
5-year range
70.4M / 71.0M
FY2022-FY2025
Trend
+0.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding has increased for 3 consecutive years, from 70364912.00 in FY2022 to 71009866.00 in FY2025.
Based on SEC 10-K filings.
71009866.00 in FY2025 with a 3-year CAGR of +0.3%.
Remained stable around 71009866.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +0.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Ovid Therapeutics Inc.'s shares outstanding has grown for 3 consecutive years.
- In FY2025, shares outstanding increased 0.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.61 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 71.0M | +0.4% |
| FY2024 | 70.7M | +0.3% |
| FY2023 | 70.5M | +0.1% |
| FY2022 | 70.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026